Combination of Miller Fisher syndrome and unspecified peripheral T-cell lymphoma
https://doi.org/10.25789/YMJ.2024.85.32
Abstract
The article presents a clinical case of combination of Miller Fisher syndrome and unspecified peripheral T-cell lymphoma, which is an aggressive disease with an extremely poor prognosis. The pathogenetic treatment of the identified syndrome did not cause an improvement in the pa- tient's condition and did not affect the expected unfavorable prognosis of the primary malignant disease, for which chemotherapy was not carried out due to the extremely serious condition of the patient. This case emphasizes the importance of an oncological search in patients with Miller Fisher syndrome and the mandatory determination of onconeural antibodies used in the diagnosis of paraneoplastic neurological syndrome, which occurs in malignant tumors of various histogenetic types.
About the Authors
A. D. Makarov
M.K. Ammosov MI NEFU
Russian Federation
Russian Federation
MAKAROV A.D. – Ph.D., Associate Professor of the Department of Hospital Surgery
L. M. Atlasova
RH No.1 – NCM
Russian Federation
Russian Federation
ATLASOVA L.M. – Doctor of the Therapy Department
A. V. Tobokhov
Medical Institute NEFU
Russian Federation
Russian Federation
TOBOKHOV A.V. – MD, Professor of the Department of Hospital Surgery
A. A. Tappakhov
M.K. Ammosov MI NEFU
Russian Federation
Russian Federation
TAPPAKHOV A.A. – Ph.D., Associate Professor of the Department of Neurology and Psychiatry
S. S. Sosina
Medical Institute NEFU
Russian Federation
Russian Federation
SOSINA S.S. – Ph.D., Associate Professor of the Department of Propaedeutic and Faculty Therapy with Physiotherapy and Endocrinology
D. N. Semenov
MI NEFU
Russian Federation
Russian Federation
SEMENOV D.N. – Ph.D., Professor of the Department of Hospital Surgery
References
1. Bolotnaya L.A., Serbina I.M. Paraneoplasticheskie dermatozy [Paraneoplastic dermatoses] Mezhdunarodnyj medicinskij zhurnal. [International Medical Journal. 2008; 3: 86–90. (In Russ.).]
2. Evtushenko S.K. Paraneoplasticheskie nevrologicheskie sindromy (klinika, diagnostika i vozmozhnosti lecheniya) [Paraneoplastic neurological syndromes (clinic, diagnosis and treatment options)]. Mezhdunarodnyj medicinskij zhurnal. [International Medical Journal. 2011; 8 (46). (In Russ.).]
3. Levin O.S. Polinevropatii: klinicheskoe rukovodstvo. [Polyneuropathies: clinical guidelines]. Moscow: MIA, 2016: 480 p. (In Russ.).]
4. Piradov M.A., Suponeva N.A. Sindrom Gijena – Barre: Diagnostika i lechenie. Monografiya. [Guillain–Barre syndrome: Diagnosis and treatment]. Monograph. Moscow: MEDpress-inform. 2011: 72-73. (In Russ.).]
5. Ponomarev V.V. Autoimmunnye zabolevaniya v nevrologii. [Autoimmune diseases in neurology]. Minsk: Belorusskaya nauka, 2010: 259. (In Russ.).]
6. Fursova L.A., Lihacheva E.M. Paraneoplasticheskie spinal'nye sindromy (nauchnyj obzor i lichnoe nablyudenie). [Paraneoplastic spinal syndromes (scientific review and personal observation)]. Mezhdunarodnyj nevrologicheskij zhurnal [International Neurological Journal. 2017; 4 (90): 69-76. (In Russ.).]
7. Schneider N.A., Dykhno Yu.A., Ezhikova V.V. et al. Paraneoplasticheskij nevrologicheskij sindrom. [Paraneoplastic neurological syndrome]. Novosibirsk. 2016:172. (In Russ.).]
8. De Silva NL, Weeratunga P, Umapathi T, et al. Miller Fisher Syndrome Developing as a Parainfectious Manifestation of Dengue Fever: A Case Report and Review of The Literature. Journal of Medical Case Reports 2019; 13(1):120.
9. Gentile S., Messina M., Rainero I. et al. Miller Fisher syndrome associated with Burkitt's lymphoma // Eur J Neurol. 2006 Apr;13(4):430. doi: 10.1111/j.1468-1331.2006.01254. x.
10. Hela J., Mariem K., Saloua F. et al. Miller Fisher Syndrome revealing a lung carcinoma: Paraneoplastic origin of Miller Fisher Syndrome? Rev Neurol (Paris). 2019;175(5):332-334. doi: 10.1016/j.neurol.2018.07.01211. Lee SY, Lee YH,
11. Chun BY, Lee SY, Cha SI, Kim CH, Park JY, Lee J. An adult case of Fisher syndrome subsequent to Mycoplasma pneumoniae infection. Journal of Korean Medical Science. 2013;28(1):152-155. https://doi.org/10.3346/jkms.2013.28.1.152
12. Maddison P. Anti-GQ1b IgG antibody syndrome without ophthalmoplegia: clinical and immunological features. Journal of Neurology, Neurosurgery, and Psychiatry. 2001; 71:282-283.
13. Muñiz AE. Multiple cranial nerve neuropathies, ataxia and areflexia: Miller Fisher syndrome in a child and review. The American Journal of Emergency Medicine. 2017;35(4):661. doi: 10.1016/j.ajem.2016.07.042.
14. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clinic Proceedings. 2010 Sep;85(9):838-54.
15. Ryu WY, Kim YH, Yoon BA, et al. Pattern of Extraocular Muscle Involvements in Miller Fisher Syndrome. Journal of Clinical Neurology. 2019; 15(3):308-12.
16. Snyder LA, Rismondo V, Miller NR. The Fisher variant of Guillain-Barre syndrome (Fisher syndrome). Journal of Neuroophthalmology. 2009; 29:312324.
17. Spyromitrou-Xioufi P., Ntoulios G., Ladomenou F. et al. Miller Fisher Syndrome Triggered by Infections: A Review of the Literature and a Case Report. J Child Neurol. 2021 Aug;36(9):785-794. doi: 10.1177/0883073820988428.
Review
For citations:
Makarov A.D., Atlasova L.M., Tobokhov A.V., Tappakhov A.A., Sosina S.S., Semenov D.N. Combination of Miller Fisher syndrome and unspecified peripheral T-cell lymphoma. Yakut Medical Journal. 2024;(1):128-131. https://doi.org/10.25789/YMJ.2024.85.32
Views:
15
Email this article 